当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-09-02 , DOI: 10.1111/apt.18195 Kanika Sehgal 1 , Dennis L Shung 2, 3
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-09-02 , DOI: 10.1111/apt.18195 Kanika Sehgal 1 , Dennis L Shung 2, 3
Affiliation
This article is linked to Forbes et al paper. To view this article, visit https://doi.org/10.1111/apt.18139
中文翻译：
社论：阿司匹林、低剂量利伐沙班或联合治疗患者严重胃肠道出血的发生率和预测因素：COMPASS 随机对照试验的二次分析
本文链接到 Forbes 等人的论文。要查看此文章，请访问 https://doi.org/10.1111/apt.18139
更新日期：2024-09-02
中文翻译：
社论：阿司匹林、低剂量利伐沙班或联合治疗患者严重胃肠道出血的发生率和预测因素：COMPASS 随机对照试验的二次分析
本文链接到 Forbes 等人的论文。要查看此文章，请访问 https://doi.org/10.1111/apt.18139
京公网安备 11010802027423号